GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Aquaporin Gene Divergence in Mytilida Linked to Salinity Adaptation

by GOAI
Share To

Researchers have identified key evolutionary adaptations in aquaporins within the Mytilida order, which includes marine bivalves such as mussels and clams. The study, published in *BMC Genomics*, examines variations in aquaporin genes across different taxa within this group. Aquaporins are membrane proteins that regulate water transport, and their divergence provides insights into how these organisms adapt to diverse environmental conditions. The research team included scientists Jia, Song, and Shen.

The investigation analyzed aquaporin gene sequences to understand their evolutionary patterns and functional differences among species in the Mytilida order. Findings suggest that specific divergences in aquaporins may play a role in enabling these bivalves to survive and thrive under varying salinity levels and other environmental stressors. The study highlights the importance of aquaporins in physiological adaptation mechanisms for marine organisms. Researchers used genomic data from multiple species to identify these variations, offering a detailed look at how genetic evolution supports ecological resilience within this group of marine life.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top